Henrik Norlin

This profile gathers the share dealings of Henrik Norlin in Re:NewCell AB. We count 4 filings; the first trade dates from 25 November 2020 and the latest from 18 December 2020.

The open-market side counts 1 purchase for €492k alongside 1 sale for €11.8M. Taken together, the sales exceed the purchases by €11.3M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The latest filing, published on 18 December 2020, reports an open-market sale of €11.8M in Re:NewCell AB. The clock since the last published purchase (27 November 2020) now reads 2,173 days. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.